$HIMS short squeeze incoming 🚀💸💰

$HIMS 1/3 of shares are shorted (52 million shares). Yesterday (January 15), the stock was already up 7%. This could lead to a massive short squeeze, especially with Sema remaining on the shortage list!

If no decision is made by the end of the week, a new acting FDA chief will take over next week (a placeholder until Trump’s official pick is confirmed). If the Biden administration didn’t declare the shortage over, the acting chief likely won’t either. Essentially, the decision will be delayed until RFK is in place—and even then, it likely won’t be a top priority. This will squeeze big! Last year Q4 earnings pushed rhe stock 50%. Fundamentals are phenomenal. Hims donated Trump. We are getrting rich.